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Background: The Ilkisonko Maasai are a Kenyan pastoralist community that uses indigenous plants for the 
management of pain and inflammatory conditions such as arthritis.  
Objectives: The purpose of this study was to validate the use of plants for medicinal purposes by the Ilkisonko Maasai 
through testing for anti-inflammatory activity using the carrageenan-induced rat paw oedema assay.  
Methodology: The methanol extracts (400 mg/kg body weight) of Rhus natalensis (bark), Acacia drepanolobium 
(bark), Acacia nilotica (bark), Acacia reficiens (bark), Acacia robusta (bark), Grewia villosa (bark), Ximenia americana 
(bark and leaves) and Rhus vulgaris (leaves) were evaluated for in vivo anti-inflammatory efficacy using the 
carrageenan-induced rat paw oedema assay. Diclofenac (20 mg/kg body weight) was used as the positive control and 
paw volume was measured by a plethysmometer.  
Results: The maximum percentage inhibition (PI) of the extracts was observed as Grewia villosa (58.6% at 24 h), Rhus 
vulgaris (57.8% at 24 h), Acacia nilotica (55.5% at 1 h), Ximenia americana (54.5% at 1 h), Acacia drepanolobium 
(50.9% at 24 h), Acacia reficiens (47.6% at 1 h), Rhus natalensis (43.8% at 24 h) and Acacia robusta (37.4% at 24 h) (p 
< 0.05 for all PI). Diclofenac (20 mg/kg) showed a steady increase in PI from 1 h to 4 h with a maximum PI of 66.2% (p 
< 0.05) at 4 h and the lowest PI of 14.3% at 24 h. 
Conclusion: All extracts of the plants assessed exhibited anti-inflammatory activity at early phase of inflammation. 
Additionally, extracts of five plants, namely Rhus natalensis, Acacia drepanolobium, Acacia robusta, Grewia villosa and 
Rhus vulgaris showed anti-inflammatory activity at both early and late phases of inflammation. There is need for 
further studies to identify phytochemicals with active anti-inflammatory activity. 
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1. Introduction 
An effective inflammatory response is necessary and 
beneficial in protecting an organism from harmful 
stimuli. However, an unresolved and prolonged 
inflammatory response leads to destruction of tissues 
involved and is evident in a number of pathologies 
(Warrington et al, 2011). In such cases, non-steroidal 
anti-inflammatory drugs (NSAIDs) and corticosteroids 
are some of the conventional drugs used to suppress 
inflammation. These drugs however, only relieve the 
inflammation but do not remove the trigger or treat its 
cause and hence may need long-term administration. 
Prolonged use of NSAIDs and corticosteroids cause side 
effects such as nephrotoxicity, hepatotoxicity, peptic 
ulcers, osteoporosis and Cushing’s syndrome (Juthani et 
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al, 2017). These side effects create a compelling medical 
need for discovery and development of novel anti-
inflammatory agents with a better safety profile. Plants 
with known ethnomedicinal uses present a potential 
source of new and potentially safer anti-inflammatory 
compounds.  
The Ilkisonko Maasai are an indigenous pastoralist 
community living mostly in the southern part of Kenya 
and northern Tanzania. They have a rich culture which 
entails the use of traditional plants to preserve health. 
This includes the dietary use of decoctions made from 
medicinal plant species prevalent in their locality as 
food additives or for prevention and treatment of 
various illnesses (Johns et al, 1999). In a previous study 
(Kimondo et al, 2015), we documented the use of 30 
plant species mainly as adaptogens, antimicrobial 
agents, and for the management of pain and 
inflammatory conditions such as arthritis among the 
Ilkisonko Maasai. Subsequent phytochemical screening 
showed that methanol extracts of eight of the 30 plant 
species had high phenolic and flavonoid content, as well 
as attractive antioxidant potential, all good indicators of 
biological activity including anti-inflammatory efficacy 
(Kimondo et al, 2019). This study therefore sought to 
further investigate the anti-inflammatory activity of the 
eight plants used by the Ilkisonko Maasai in folk 
medicine (Kimondo et al, 2015). The plants investigated 
in this study are Rhus natalensis, Acacia drepanolobium, 
Acacia nilotica, Acacia reficiens, Acacia robusta, Grewia 
villosa, Ximenia americana and Rhus vulgaris. Several 
plants in the genera investigated in this study, have 
previously reported in vitro or in vivo anti-inflammatory 
activity. Methanol and aqueous root bark extracts of 
Grewia asiatica (Paviaya et al, 2013), methanol extract 
of Rhus vulgaris leaves (Odongo et al, 2017), aqueous 
extract of Acacia nilotica pods (Dafallah and Al-Mustafa, 
1996) and leaves and root extracts of Ximenia caffra 
(Mulaudzi et al, 2013) showed anti-inflammatory 
activity in cell and animal models. This study reports for 
the first time the anti-inflammatory activity of methanol 
extracts of Rhus natalensis, Acacia nilotica, Acacia 
drepanolobium, Acacia reficiens, Acacia robusta, Grewia 
villosa and Ximenia americana. The methanol extracts 
were used because they had been previously shown to 
have significantly higher total phenol, total flavonoid 
content and antioxidant activity than their 
corresponding aqueous extracts (Kimondo et al, 2019). 
2. Methods 
2.1 Materials, reagents and equipment 
Lambda-carrageenan (22049), diclofenac sodium, 
methanol and dimethyl sulfoxide (DMSO) were 
obtained from Sigma Aldrich Co. (St Louis, MO, USA). 
Normal saline solution was bought from Dawa Limited 
(Nairobi, Kenya). Büchi Rotavapor R-200 rotary 
evaporator (Büchi Labortechnik, Flawil) was used to 
evaporate extracting methanol from the plant extracts. 
Plethysmometer LE 7500 (Panlab Harvard) was used to 
measure the rat paw oedema. 
2.2 Plant collection and preparation of extracts 
The medicinal plants were collected in December 2014, 
identified, catalogued and voucher specimens deposited 
at the University of Nairobi herbarium (Kimondo et al, 
2015). These were Rhus natalensis (JW2014/02) root 
bark; Acacia drepanolobium (JW2014/09) stem bark; 
Acacia nilotica (JW2014/10) stem bark; Acacia reficiens 
(JW2014/12) root bark; Acacia robusta (JW2014/15) 
stem bark; Grewia villosa (JW2014/18) root and stem 
bark; Ximenia americana (JW2014/19) stem bark and 
leaves; and Rhus vulgaris (EAO2016/063) leaves 
(Odongo et al, 2017; Kimondo et al, 2019).  
The appropriate plant parts were dried under shade at 
ambient temperature and pulverized to a fine powder. 
Methanol extract was obtained by macerating the 
powder in six times its weight using 80% v/v methanol 
at room temperature for 72 h. The extracts were 
filtered, concentrated under vacuum, and dried further 
in an oven at 40°C for 24 h. 
2.3 Experimental animals 
Adult Wistar rats weighing 190-250 grams were 
obtained from Small Animal Facility for Research and 
Innovation (SAFARI) of the Jomo Kenyatta University of 
Science and Technology. They were kept at a maximum 
of five per cage (435 × 290 × 150 mm) in a well-
ventilated animal house with room temperature 
maintained at 20-25°C with a 12 h light/dark cycle. The 
animals had ad libitum access to rat chow (Unga 
Feeds™) and clean drinking water. Animal beddings 
comprising of saw dust, was changed once daily. The 
rats were allowed to habituate for one week before 
experimentation. Prior to the carrageenan-induced rat 
paw oedema test, they were fasted overnight but 
provided with water ad libitum.  
2.4 Carrageenan induced rat paw oedema test 
Carrageenan induced rat paw oedema was carried out 
as previously described (Ganga et al, 2012). Ten groups 
of five adult Wistar rats each, received either methanol 
plant extracts (400 mg/kg body weight), diclofenac (20 
mg/kg body weight), or vehicle control (distilled water) 
in 3% w/w DMSO orally 1 h before the carrageenan 
injection (Adedapo et al, 2008). Acute inflammation was 
induced by the sub-plantar administration of 0.1 ml of 
1% w/v carrageenan in normal saline in the right hind 
paw of the rats. The paw volume was measured (up to 
the tibio-tarsal junction) at time 0 (immediately before 
the injection), 1, 2, 3, 4 and 24 h after carrageenan 
injection by the volume displacement method using a 
digital plethysmometer. An increase in the volume of 
the paw was taken as an indication of oedema. The 
percentage inhibition (PI) of the inflammation was 
calculated (Pérez González et al, 2013; Meshram et al, 
2016). 
2.5 Statistical analysis 
Data were expressed as mean paw volume. The 
descriptive statistics were the standard deviation of the 
mean and the corresponding percentage inhibition of 
inflammation calculated. The difference in response was 
analysed using ANOVA followed by the post hoc Tukey’s 
test. A p-value of < 0.05 was considered significant.  
2.6 Ethical considerations 
Ethical approval for this study was obtained from 
Kenyatta National Hospital-University of Nairobi 
Kimondo et al, Afr. J. Pharmacol. Ther. 2020. 9(2): 39-43 
 
A KeSoBAP Publication ©2020. All rights reserved. 
41 
Research Ethics Review Committee 
(KNH/ERC/A/173). The animal care and use protocol 
was approved by the Small Animal Facility for Research 
and Innovation (SAFARI) Animal Ethics Committee, 
Jomo Kenyatta University of Agriculture and 
Technology. 
3. Results  
Diclofenac (20 mg/kg) showed a steady increase in PI 
from 1 h to 4 h with a maximum PI of 66.2% at 4 h and 
the lowest PI of 14.3% at 24 h. All methanol extracts 
(400 mg/kg) showed significant inhibition of 
carrageenan rat paw oedema at 1 h compared to the 
negative control. Most extracts (RN, AD, AB, GV and RV) 
showed a constant decline in PI from 1 h to 3 h or 4 h 
except for AN, AR and XA which had their lowest PI at 
24 h (14.3%, 17.4% and 17.4% respectively). Though 
the PI values for AN, AR and XA consistently declined 
from 1 h to 4 h, only the PIs of AN and XA were 
significantly different from the negative control at all 4 
time points (AN- 55.5%, 45.8%, 32.8% and 27.8%; XA- 
54.5%, 45.0%, 44.6% and 50.6%). The maximum PI for 
the methanol extracts was observed as GV (58.6% at 1 
h), RV (57.8% at 24 h), AN (55.5% at 1 h), XA (54.5% at 
1 h), AD (50.9% at 24 h), AR (47.6% at 1 h), RN (43.8% 
at 24 h) and AB (37.4% at 24 h). The following 
methanol extracts showed their highest PIs of 
inflammation at 1 h and 24 h, respectively; RN (41.9% 
and 43.8%), AD (40.3% and 50.9%), AB (37.2% and 
37.4%), GV (58.6% and 55.1%) and RV (35.9% and 
57.8%) (Table 1). 
 
Table 1: Anti-inflammatory effects of the select plant extracts on carrageenan-induced rat paw oedema. 
 
Mean paw volume in mL ± SD (% inhibition, n=5) at the respective times 
CODE 0 h 1 h 2 h 3 h 4 h 24 h 
C 0.86±0.11 1.24±0.21 1.38±0.22 1.45±0.22 1.56±0.22 1.39±0.14 
DC 
0.92±0.07 
1.10 ±0.08* 
(52.9) 
1.17±0.07* 
(52.7) 
1.20±0.08* 
(54.1) 
1.16±0.08* 
(66.2) 
1.38±0.06 
(14.3) 
RN 
0.78±0.06 
1.00±0.06* 
(41.9) 
1.16±0.06 
(28.6) 
1.28±0.06 
(15.5) 
1.29±0.09 
(27.3) 
1.08±0.07* 
(43.8) 
AD 
1.08±0.08 
1.31±0.08* 
(40.3) 
1.46±0.06 
(27.1) 
1.53±0.04 
(23.7) 
1.57±0.03* 
(30.4) 
1.34±0.06* 
(50.9) 
AN 
0.95±0.12 
1.12±0.12* 
(55.5) 
1.23±0.11* 
(45.8) 
1.35±0.14* 
(32.8) 
1.46±0.16* 
(27.8) 
1.40±0.11 
(14.3) 
AR 
0.91±0.12 
1.11±0.12* 
(47.6) 
1.28±0.15* 
(30.5) 
1.36±0.15 
(24.7) 
1.47±0.17 
(20.7) 
1.35±0.15 
(17.4) 
AB 
0.87±0.08 
1.11±0.08* 
(37.2) 
1.23±0.05 
(31.7) 
1.32±0.09 
(24.7) 
1.32±0.09* 
(36.7) 
1.20±0.04* 
(37.4) 
GV 
1.09±0.13 
1.25±0.13* 
(58.6) 
1.41±0.17* 
(39.3) 
1.52±0.19 
(28.4) 
1.62±0.19 
(25.6) 
1.33±0.16* 
(55.1) 
XA 
0.90±0.04 
1.08±0.06* 
(54.5) 
1.19±0.06* 
(45.0) 
1.23±0.06* 
(44.6) 
1.25±0.06* 
(50.6) 
1.34±0.04 
(17.4) 
RV 
0.86±0.06 
1.08±0.07* 
(35.9) 
1.18±0.07* 
(33.7) 
1.27±0.06 
(26.4) 
1.29±0.07* 
(32.9) 
1.03±0.08* 
(57.8) 
Key: C- negative control; DC- positive control (diclofenac); RN- Rhus natalensis; AD- Acacia drepanolobium; AN- Acacia nilotica; AR- 
Acacia reficiens; AB- Acacia robusta; GV- Grewia villosa; XA- Ximenia americana; RV- Rhus vulgaris. * Statistically significant p < 0.05. 
 
4.0 Discussion 
An injection of carrageenan has been shown to induce 
biphasic paw oedema in rats (Patrono and Baigent, 
2014). Mediators such as serotonin and histamine are 
responsible for the swelling, redness and pain 
experienced during the early phase of inflammation. 
These mediators then induce cyclooxygenase (COX) 2 
and its products, which start the second phase of 
inflammation (Fernando et al, 2005). Diclofenac showed 
significant anti-inflammatory activity, which 
consistently rose from the first to the fourth hour, with 
the highest PI at 66.2% (4 h). This is in agreement with 
a previous study showing a similar PI after oral 
administration of diclofenac (20 mg/kg) (Sakat et al, 
2014). Diclofenac has a short half-life (Schweitzer et al, 
2009) as illustrated by its weak activity at 24 h with a PI 
of 14.3%.  
Acacia nilotica and Ximenia americana significantly 
inhibited paw oedema from 1 to 4 hours (AN- 55.5, 45.8, 
32.8 and 27.8; XA- 54.5, 45.0, 44.6 and 50.6). This is in 
concurrence with previously observed anti-
inflammatory activity of phytochemicals from these two 
plants. Niloticane, a diterpene from the bark of Acacia 
nilotica, has been reported to exhibit good COX-2 
inhibitory activity (Eldeen et al, 2010) while 
polysaccharide rich fractions from Ximenia americana 
have anti-inflammatory and anti-nociceptive activity 
(Da Silva-Leite et al, 2017). Also, in Brazil, a topical 
ointment of Ximenia americana branch extract, 
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exhibited significant anti-inflammatory activity (Neto 
Júnior et al, 2019). 
All methanol extracts of the plants assayed had anti-
inflammatory activity during the early phase, 
potentially indicating the presence of compounds that 
inhibit biological actions of serotonin and histamine. As 
previously reported, the plants assayed in this study 
had high polyphenol content (Kimondo et al, 2019). 
Polyphenols have been shown to reduce the levels of 
pro-inflammatory markers in mice and slow down the 
progression of inflammation (Aboura et al, 2017). Gallic 
acid, a phenolic acid common in all genera evaluated in 
the current study, was previously reported to reduce 
expression of COX-2 and pro-inflammatory cytokines in 
vitro (BenSaad et al, 2017). Umbelliferone, a flavonoid 
from Acacia species, was found to reduce the 
production of inflammatory markers and increase 
apoptosis of abnormal cells, processes that can promote 
resolution of inflammation (Muthu et al, 2016). The 
good anti-inflammatory activity exhibited by Rhus 
natalensis, Acacia drepanolobium, Acacia robusta, 
Grewia villosa and Rhus vulgaris extracts during the 
early and delayed phases may be an indicator of the 
presence of such compounds acting during both phases. 
It could also mean the presence of more active 
metabolites 24 h after administration of the extract. 
Further, flavonoids in wine have been found to retain 
anti-inflammatory activity even after metabolism as 
compared to diclofenac metabolites which are only 
weakly active (Davies and Anderson, 1997; Fernandes 
et al, 2017). Apart from the phenolic compounds, other 
phytochemicals such as the triterpenoids from the 
Acacia and Grewia genera (lupenone and lupandiol, 
respectively) significantly decrease acute and subacute 
inflammation in mice as well as interlukin-1β and 
interferon-γ levels (Ahmadu et al, 2010; Xu et al, 2019). 
5.0 Conclusion  
The methanol extracts of all the plants assayed showed 
anti-inflammatory activity at the early phase of 
inflammation. Plant extracts with anti-inflammatory 
activity in both early and late phases were Rhus 
natalensis, Acacia drepanolobium, Acacia robusta, 
Grewia villosa and Rhus vulgaris. However, for a better 
understanding of the differences in efficacy, there is a 
need for further studies with different doses of each 
extract in order to get a dose-response relationship as 
well as determine the 50% inhibitory doses (ID50).  
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